The Food and Drug Administration is working to develop a regulatory policy for CBD. The U.S. Food and Drug Administration detailed its concerns regarding the safety of CBD on Tuesday while issuing warnings to 15 companies the agency says are illegally marketing products containing the cannabinoid. In a consumer update posted to its website, the FDA said that only one pharmaceutical, Epidiolex, has been approved by the agency for the treatment of patients with two rare forms of epilepsy. For oth...
Browse Article Categories
FDA Details CBD Safety Concerns, Warns Firms of Illegal Practices
Rate this article
No Comments Yet
Be the first to share what you think!